1.Clinical and echocardiographic differences between rheumatic and degenerative mitral stenosis.
Ryan LEOW ; Ching-Hui SIA ; Tony Yi-Wei LI ; Meei Wah CHAN ; Eng How LIM ; Li Min Julia NG ; Tiong-Cheng YEO ; Kian-Keong POH ; Huay Cheem TAN ; William Kf KONG
Annals of the Academy of Medicine, Singapore 2025;54(4):227-234
INTRODUCTION:
Degenerative mitral stenosis (DMS) is frequently cited as increasing in prevalence in the developed world, although comparatively little is known about DMS in comparison to rheumatic mitral stenosis (RMS).
METHOD:
A retrospective observational study was conducted on 745 cases of native-valve mitral stenosis (MS) with median follow-up time of 7.25 years. Clinical and echocardiographic parameters were compared. Univariate and multivariate Cox regression analyses were performed for a composite of all-cause mortality and heart failure hospitalisation.
RESULTS:
Patients with DMS compared to RMS were older (age, mean ± standard deviation: 69.6 ± 12.3 versus [vs] 51.6 ± 14.3 years, respectively; P<0.001) and a greater proportion had medical comorbidities such as diabetes mellitus (78 [41.9%] vs 112 [20.0%], P<0.001). The proportion of cases of degenerative aetiology increased from 1.1% in 1991-1995 to 41.0% in 2016-2017. In multivariate analysis for the composite outcome, age (hazard ratio [HR] 95% confidence interval [CI] of 1.032 [1.020-1.044]; P<0.001), diabetes mellitus (HR 1.443, 95% CI 1.068-1.948; P=0.017), chronic kidney disease (HR 2.043, 95% CI 1.470-2.841; P<0.001) and pulmonary artery systolic pressure (HR 1.019, 95% CI 1.010- 1.027; P<0.001) demonstrated significant indepen-dent associations. The aetiology of MS was not independently associated with the composite outcome.
CONCLUSION
DMS is becoming an increasingly common cause of native-valve MS. Despite numerous clinical differences between RMS and DMS, the aetiology of MS did not independently influence a composite of mortality or heart failure hospitalisation.
Humans
;
Mitral Valve Stenosis/etiology*
;
Male
;
Female
;
Retrospective Studies
;
Middle Aged
;
Aged
;
Rheumatic Heart Disease/mortality*
;
Echocardiography
;
Hospitalization/statistics & numerical data*
;
Heart Failure/epidemiology*
;
Singapore/epidemiology*
;
Proportional Hazards Models
;
Diabetes Mellitus/epidemiology*
2.Fatal subarachnoid haemorrhage in a patient with severe dengue
Seng Wee Cheo ; Qin Jian Low ; Eng Kian Ng ; Yuen Kang Chia ; Giri Shan Rajahram
The Medical Journal of Malaysia 2021;76(1):107-109
Dengue fever is one of the commonest tropical disease in
the tropics. It can present with mild acute febrile illness to
severe organ failure. Reported neurological complications
of dengue include dengue encephalopathy, encephalitis,
transverse myelitis and intracranial haemorrhage.
Intracranial haemorrhage in dengue can present as subdural
haematoma, extradural haematoma, intracerebral
haemorrhage and subarachnoid haemorrhage. We report
here a case of subarachnoid haemorrhage in a patient with
severe dengue. Our patient was a 30-year-old man who
presented with acute febrile illness. He subsequently
developed plasma leakage and upper gastrointestinal
bleeding. He then had reduced conscious level. Computed
tomography of his brain showed subarachnoid
haemorrhage. He eventually succumbed to his illness.
3.Current Status and Growth of Nuclear Theranostics in Singapore
Hian Liang HUANG ; Aaron Kian Ti TONG ; Sue Ping THANG ; Sean Xuexian YAN ; Winnie Wing Chuen LAM ; Kelvin Siu Hoong LOKE ; Charlene Yu Lin TANG ; Lenith Tai Jit CHENG ; Gideon Su Kai OOI ; Han Chung LOW ; Butch Maulion MAGSOMBOL ; Wei Ying THAM ; Charles Xian Yang GOH ; Colin Jingxian TAN ; Yiu Ming KHOR ; Sumbul ZAHEER ; Pushan BHARADWAJ ; Wanying XIE ; David Chee Eng NG
Nuclear Medicine and Molecular Imaging 2019;53(2):96-101
The concept of theranostics, where individual patient-level biological information is used to choose the optimal therapy for that individual, has become more popular in the modern era of ‘personalised’ medicine. With the growth of theranostics, nuclear medicine as a specialty is uniquely poised to grow along with the ever-increasing number of concepts combining imaging and therapy. This special report summarises the status and growth of Theranostic Nuclear Medicine in Singapore.We will cover our experience with the use of radioiodine, radioiodinated metaiodobenzylguanidine, peptide receptor radionuclide therapy, prostate specific membrane antigen radioligand therapy, radium-223 and yttrium-90 selective internal radiation therapy.We also include a section on our radiopharmacy laboratory, crucial to our implementation of theranostic principles. Radionuclide theranostics has seen tremendous growth and we hope to be able to grow alongside to continue to serve the patients in Singapore and in the region.
Hope
;
Humans
;
Lutetium
;
Membranes
;
Nuclear Medicine
;
Prostate
;
Radium
;
Receptors, Peptide
;
Singapore
;
Theranostic Nanomedicine
;
Yttrium
4.Current Status and Growth of Nuclear Theranostics in Singapore
Hian Liang HUANG ; Aaron Kian Ti TONG ; Sue Ping THANG ; Sean Xuexian YAN ; Winnie Wing Chuen LAM ; Kelvin Siu Hoong LOKE ; Charlene Yu Lin TANG ; Lenith Tai Jit CHENG ; Gideon Su Kai OOI ; Han Chung LOW ; Butch Maulion MAGSOMBOL ; Wei Ying THAM ; Charles Xian Yang GOH ; Colin Jingxian TAN ; Yiu Ming KHOR ; Sumbul ZAHEER ; Pushan BHARADWAJ ; Wanying XIE ; David Chee Eng NG
Nuclear Medicine and Molecular Imaging 2019;53(2):96-101
The concept of theranostics, where individual patient-level biological information is used to choose the optimal therapy for that individual, has become more popular in the modern era of ‘personalised’ medicine. With the growth of theranostics, nuclear medicine as a specialty is uniquely poised to grow along with the ever-increasing number of concepts combining imaging and therapy. This special report summarises the status and growth of Theranostic Nuclear Medicine in Singapore.We will cover our experience with the use of radioiodine, radioiodinated metaiodobenzylguanidine, peptide receptor radionuclide therapy, prostate specific membrane antigen radioligand therapy, radium-223 and yttrium-90 selective internal radiation therapy.We also include a section on our radiopharmacy laboratory, crucial to our implementation of theranostic principles. Radionuclide theranostics has seen tremendous growth and we hope to be able to grow alongside to continue to serve the patients in Singapore and in the region.
5.Postmastectomy/Axillary Node Dissection Chyloma: The Additional Value of SPECT/CT Lymphoscintigraphy.
Sue Ping THANG ; Aaron Kian Ti TONG ; David Chee Eng NG
Journal of Breast Cancer 2014;17(3):291-294
After mastectomy and axillary node dissection, chylous leakage is rare. However, considerable anatomical variation in the termination of the thoracic duct has been reported. Hence, during breast surgery, injury to the lateral terminating branch is not unlikely and might lead to retrograde chyle leak. Herein, we describe a patient who had a chylous leakage at her wound site after a left simple mastectomy and axillary node dissection and for whom lymphoscintigraphy with Tc-99m albumin nanocolloid was performed. In this case, additional hybrid single-photon emission computed tomography/computed tomography study was done, and has helped with the accurate identification of the chyle leakage site, thus aiding in surgical management.
Breast
;
Breast Neoplasms
;
Chyle
;
Humans
;
Lymphoscintigraphy*
;
Mastectomy
;
Mastectomy, Simple
;
Thoracic Duct
;
Tomography, Emission-Computed, Single-Photon
;
Wounds and Injuries


Result Analysis
Print
Save
E-mail